H.R.2756 - National Biotechnology Initiative Act of 2025 (119th Congress)
Summary
H.R.2756, the National Biotechnology Initiative Act of 2025, aims to advance national security, economic productivity, and competitiveness through the coordination of federal activities related to biotechnology. The bill establishes the National Biotechnology Initiative, involving multiple federal agencies and coordinated by a National Biotechnology Coordination Office within the Executive Office of the President. It outlines various activities, including research and development, data management, regulatory streamlining, workforce development, and international partnerships.
Expected Effects
The Act is likely to foster innovation and growth in the biotechnology sector. It will create a more coordinated federal approach to biotechnology. This could lead to advancements in various fields, including healthcare, agriculture, and national security. The establishment of clear regulatory pathways and workforce development programs could also stimulate economic growth and job creation.
Potential Benefits
- Enhanced national security through biotechnology advancements.
- Increased economic productivity and competitiveness in the biotechnology sector.
- Streamlined regulatory processes for biotechnology products.
- Development of a skilled domestic workforce in biotechnology.
- Improved coordination and collaboration among federal agencies involved in biotechnology.
Potential Disadvantages
- Potential for increased government spending and bureaucracy.
- Risk of over-regulation stifling innovation.
- Concerns about the ethical and social implications of biotechnology advancements.
- Possible misuse of biotechnology for harmful purposes.
- Challenges in balancing economic competitiveness with national security and ethical considerations.
Constitutional Alignment
The bill appears to align with the Constitution's mandate to "promote the general Welfare" (Preamble) by fostering advancements in biotechnology that could benefit public health, agriculture, and other sectors. The establishment of the National Biotechnology Initiative and the coordination of federal activities are within the powers granted to the Executive Branch under Article II of the Constitution. Congress's power to appropriate funds for the initiative is derived from Article I, Section 8, which grants Congress the power to lay and collect taxes, duties, imposts, and excises, to pay the debts and provide for the common defense and general welfare of the United States.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).